Listed

Viemed Healthcare, Inc.: Form 10-Q for the period ended Jun 30, 2023

Filed with the SEC on Aug 9, 2023 and accepted by EDGAR at Aug 9, 2023, 16:19 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2023-06-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2023-04-01 to 2023-06-30$43.3mus-gaap:Revenues
Revenue6 months2023-01-01 to 2023-06-30$82.9mus-gaap:Revenues
Cost of revenue3 months2023-04-01 to 2023-06-30$17.2mus-gaap:CostOfGoodsAndServicesSold
Cost of revenue6 months2023-01-01 to 2023-06-30$32.8mus-gaap:CostOfGoodsAndServicesSold
Gross profit3 months2023-04-01 to 2023-06-30$26.1mus-gaap:GrossProfit
Gross profit6 months2023-01-01 to 2023-06-30$50.1mus-gaap:GrossProfit
Research and development3 months2023-04-01 to 2023-06-30$758.0kus-gaap:ResearchAndDevelopmentExpense
Research and development6 months2023-01-01 to 2023-06-30$1.5mus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative3 months2023-04-01 to 2023-06-30$20.6mus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative6 months2023-01-01 to 2023-06-30$40.3mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2023-04-01 to 2023-06-30$2.9mus-gaap:OperatingIncomeLoss
Operating income6 months2023-01-01 to 2023-06-30$4.8mus-gaap:OperatingIncomeLoss
Income tax3 months2023-04-01 to 2023-06-30$728.0kus-gaap:IncomeTaxExpenseBenefit
Income tax6 months2023-01-01 to 2023-06-30$1.2mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2023-04-01 to 2023-06-30$2.3mus-gaap:NetIncomeLoss
Net income6 months2023-01-01 to 2023-06-30$3.8mus-gaap:NetIncomeLoss
Diluted EPS3 months2023-04-01 to 2023-06-30$0.06us-gaap:EarningsPerShareDiluted
Diluted EPS6 months2023-01-01 to 2023-06-30$0.10us-gaap:EarningsPerShareDiluted
Basic EPS3 months2023-04-01 to 2023-06-30$0.06us-gaap:EarningsPerShareBasic
Basic EPS6 months2023-01-01 to 2023-06-30$0.10us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2023-04-01 to 2023-06-3040,676,951 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)6 months2023-01-01 to 2023-06-3040,383,616 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow6 months2023-01-01 to 2023-06-30$18.1mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure6 months2023-01-01 to 2023-06-30$10.8mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Share repurchases6 months2023-01-01 to 2023-06-30$0us-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2023-06-30$10.2mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2023-06-30$35.9mus-gaap:AssetsCurrent
Total assetsAt period end2023-06-30$149.1mus-gaap:Assets
Current liabilitiesAt period end2023-06-30$31.6mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2023-06-30$44.6mus-gaap:Liabilities
Long-term debtAt period end2023-06-30$12.1mus-gaap:LongTermDebtNoncurrent
Current portion of debtAt period end2023-06-30$3.2mus-gaap:LongTermDebtCurrent
Shareholders' equityAt period end2023-06-30$104.5mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001729149-23-000111. Last ingested by Listed: Nov 4, 2026, 19:03 ET. Listed shows no prices and gives no investment advice.